SEARCH RESULTS

329939 RESULTS

Research Brief: Meta-Analysis Finds Memantine Forgettable for Mild AD

RESEARCH NEWS 2011-04-22 Research News Memantine is one of only four commonly prescribed drugs for the treatment of memory loss in Alzheimer’s disease. The FDA approved the drug for moderate to severe AD in 2003, but since then many physicians have taken to prescribing it off-lab

Stress and Trauma: Shaken Brains, Shaken Lives

RESEARCH NEWS 2011-04-22 Research News Athletes who suffer repeated concussions in high-impact sports such as boxing, football, and hockey are at risk for long-term brain damage. Some of them develop a degenerative condition known as chronic traumatic encephalopathy (CTE), also c

Las Vegas: Lou Ruvo Center Pioneers New Approach to Clinical Trials

CONFERENCE COVERAGE 2011-04-22 Conference Coverage A mere stone’s throw from shady bookstores and rundown bail bond shops stands an $80 million steel spectacle that Las Vegas mayor Oscar Goodman hopes will help revitalize this part of town. The landmark building is also poised to stren

PAPER Gavrilova SI, Kolykhalov IV, Fedorova YB, Selezneva ND, Kalyn YB, Roshchina IF, Odinak MM, Emelin AY, Kashin AV, Gustov AV, Antipenko EA, Korshunova YA, Davydova TA, Messler G

Potential of preventive treatment of Alzheimer's disease: results of a three-year prospective open comparative trial of the efficacy and safety of courses of treatment with cerebrolysin and cavinton in elderly patients with mild cognitive impairment syndr

Neurosci Behav Physiol. 2011 May;41(4):391-8. PubMed: 21505745

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE